Antimalarial effect of B.663 in mice infected with Plasmodium berghei.
D000814:Aniline Compounds / Q000627:therapeutic use; D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use*; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D051379:Mice; D010619:Phenazines / Q000627:therapeutic use*; D010961:Plasmodium / Q000187:drug effects
D000814:Aniline Compounds; D000962:Antimalarials; D010619:Phenazines